UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021242
Receipt number R000024327
Scientific Title Study on the diagnostic method based on the Study of the diagnostic method on the Prediction of bone strength by a quantitative computed tomography-based finite element method
Date of disclosure of the study information 2016/04/01
Last modified on 2018/09/03 10:23:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the diagnostic method based on the Study of the diagnostic method on the Prediction of bone strength by a quantitative computed tomography-based finite element method

Acronym

Study on the diagnosis by the finite element method

Scientific Title

Study on the diagnostic method based on the Study of the diagnostic method on the Prediction of bone strength by a quantitative computed tomography-based finite element method

Scientific Title:Acronym

Study on the diagnosis by the finite element method

Region

Japan


Condition

Condition

Osteoporosis

Classification by specialty

Endocrinology and Metabolism Geriatrics Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To track the transition of the predicted bone strength value by the bone density values and the CT finite element method by DXA before and after the treatment of osteoporosis intervention, to compare the sensitivity of the therapeutic effect of each diagnostic method.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Predicted Bone strength 0,6,12,24months

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

medical treatment with minodronic acid
Period of 24 months

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Osteoporosis was diagnosed based on Diagnostic criteria for primary osteoporosis : year 2012 revision

Key exclusion criteria

Exclusion criteria included those who had any recent or current treatment with the potential to alter bone turnover or bone metabolism, patients with dementia, those who could not walk, patients with malignancy, and those who could not take orally bisphosphonate.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name HIROSHI OKAZAKI

Organization

Japan Labour Health and Welfare Organization, Kanto Rosai Hospital

Division name

Orthopedics

Zip code


Address

1-1 Kizukisumiyoshi-cho, Nakahara-ku, Kawasaki City, Kanagawa Prefecture

TEL

044-411-3131

Email

okazarov@kantoh.rofuku.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name MASAKO KANEKO

Organization

Japan Labour Health and Welfare Organization, Kanto Rosai Hospital

Division name

Orthopedics

Zip code


Address

1-1 Kizukisumiyoshi-cho, Nakahara-ku, Kawasaki City, Kanagawa Prefecture

TEL

044-411-3131

Homepage URL


Email

masako-k@umin.net


Sponsor or person

Institute

Japan Labour Health and Welfare Organization, Kanto Rosai Hospital

Institute

Department

Personal name



Funding Source

Organization

ONO PHARMACEUTICAL CO., LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関東労災病院


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 04 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 06 Month 30 Day

Date trial data considered complete

2020 Year 08 Month 31 Day

Date analysis concluded

2020 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2016 Year 02 Month 29 Day

Last modified on

2018 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024327


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name